Chemoprotection of the ovary: a leading role or a complementary strategy in fertility preservation?

Affiliations

• ¹ IRCCS Ospedale Policlinico San Martino, Genova, Italy.
• ² DINOGMI Department, University of Genova, Genova, Italy.
• ³ Ar-Razzi Private Hospital, IVF Centre, Ramadi, Iraq.
• ⁴ Department of Obstetrics and Gynaecology, College of Medicine, University of Anbar, Ramadi, Iraq.
• ⁵ Westmead Fertility Centre, Institute of Reproductive Medicine, University of Sydney, Westmead, NSW, Australia.
• ⁶ Independent Researcher, London, UK.
• ⁷ EUGIN Group, R&D, Barcelona, Spain.
• ⁸ HealthPlus Fertility Center, HealthPlus Network of Specialty Centers, Abu Dhabi, United Arab Emirates.
• ⁹ Biomedical Sciences, University of Edinburgh, Edinburgh, UK.
• ¹⁰ Department of Anatomy and Developmental Biology, Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
• ¹¹ Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
• ¹² Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy.
• ¹³ Kinderwunschzentrum, Klinik für Reproduktions-Endokrinologie, Universitätsspital Zürich, Zurich, Switzerland.